from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3415c/-

LFCtreatmentdescriptionclass of inhibitor

0.313

Amikacinug/mL Amikacintranslation

-0.259

Cap5-10ug/mL Capreomycintranslation

0.405

Rox10-50 ug/mL Roxithromycintranslation

1.096

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

0.115

Rif0.2-5ug/mL Rifampicintranscription

0.006

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.635

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.539

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.635

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.192

Clofazimine10-13 ug/mL Clofaziminerespiration

0.109

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.663

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.463

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.913

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.977

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.653

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.499

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.390

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.632

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.708

Nigericin50 uM Nigericinrespiration

0.264

TRC10-150 ug/mL Triclosanrespiration

0.791

TRZ10-25 ug/mL Thioridazinerespiration

0.986

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.182

menadione6-10 ug/mL Menadionerespiration

-0.216

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.232

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.231

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.947

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.172

NRP_1Non-replicating persistence stage 1dosRassociated

0.200

Amp0.2mg/mL AmpicillincellWall

0.045

Cephalexin20-100 ug/mL CephalexincellWall

1.481

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.849

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.010

EMB10-20 ug/mL EthambutolcellWall

0.671

Eta12-40 ug/mL EthionamidecellWall

0.780

INH0.2-0.4 ug/mL IsoniazidcellWall

-1.055

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.427

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.198

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.792

BZA0.12 mg/mL BenzamidearomaticAmides

-0.541

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.477

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.116

H2O24 mM hydrogen peroxideDNAdamaging

-0.133

Levo10 ug/mL LevofloxacinDNAdamaging

-0.075

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.989

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.435

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.436

UVUV-irradiationDNAdamaging

0.082

ARP41-4 ug/mL Antitubercular compound ARP4?

1.158

Antimycin12.5-50 ug/mL Antimycin A?

-0.958

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.427

PA_110-50 ug/mL Antitubercular compound PA-1?

0.861

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.564

PA8240.2-2 ug/mL PA-824?

1.032

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.588

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.544

Verapamil50 uM Verapamil?

-0.992

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.054

methoxatin10-20 ug/mL Methoxatin?